Key Insights

Highlights

Success Rate

67% trial completion

Treatment Research

12 treatments under study, led by Propofol Sedation

Research Leaders

12 sponsors active, led by Chang Gung Memorial Hospital

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 54/100

Termination Rate

22.2%

2 terminated out of 9 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results67% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (4)
Phase 3 (1)
Phase 4 (3)

Trial Status

Completed4
Unknown3
Terminated2

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (9)

Research Network

Common Treatments

  • Propofol Sedation1
  • Learningcurvebased Training Modality1
  • Tci Titration By Different Cet1
  • Bispectral Index Guide Propofol Infusion1
  • Fospropofol Disodium1

Active Sponsors

  • Chang Gung Memorial Hospital2
  • Peking University People's Hospital1
  • Copenhagen University Hospital at Herlev1
  • PPD Development, LP1
  • Quest Pharmaceutical Services1

Top Investigators

Related Conditions

  • Sedation2
  • Thoracic Anesthesia1
  • Satisfaction1
  • Copd1
  • Selective Bronchial Intubation1

Activity Timeline